BACKGROUND:The 5-hydroxytryptamine system is one of the earliest-developing systems in mammals,playing crucial roles in diverse physiological processes throughout the entire life cycle.Traditionally,research on 5-hydroxytryptamine has primarily focused on its regulatory roles in physiological processes and central nervous system-related diseases.However,recent studies have also highlighted the significant roles of the 5-hydroxytryptamine system in the regenerative medicine.OBJECTIVE:To review the reparative functions of the central 5-hydroxytryptamine system in brain injury,spinal cord injury,and bone remodeling,as well as the roles of the peripheral 5-HT system in the regeneration and repair of tissues such as the liver,pancreas,intestines,and skin,thereby offering new insights into the development of therapeutic strategies in stem cell therapy,tissue engineering,and regenerative medicine.METHODS:A comprehensive literature search was conducted using the databases"PubMed"and"Google Scholar."The search terms included:"5-HT,""regeneration,""tissue repair,""5-HT and tissue repair,""brain injury,""spinal cord injury,""bone reconstruction,""liver regeneration,""enteric nerve regeneration,""tissue fibrosis,""pancreatic regeneration,""skin repair,"and"inflammation."Based on the inclusion and exclusion criteria,118 articles and books were finally included for review and analysis.RESULTS AND CONCLUSION:(1)The central 5-hydroxytryptamine system facilitates cellular regeneration in injuries such as brain damage,spinal cord injury,and bone remodeling,thereby promoting tissue repair following injuries.(2)The peripheral 5-hydroxytryptamine system plays a positive role in the repair of tissues such as the liver,pancreas,intestines,and skin.(3)However,the 5-hydroxytryptamine system also exhibits adverse effects in tissue repair and regeneration,such as promoting tissue fibrosis and exacerbating inflammation.Therefore,it should be used with caution.

BACKGROUND:The 5-hydroxytryptamine system is one of the earliest-developing systems in mammals,playing crucial roles in diverse physiological processes throughout the entire life cycle.Traditionally,research on 5-hydroxytryptamine has primarily focused on its regulatory roles in physiological processes and central nervous system-related diseases.However,recent studies have also highlighted the significant roles of the 5-hydroxytryptamine system in the regenerative medicine.OBJECTIVE:To review the reparative functions of the central 5-hydroxytryptamine system in brain injury,spinal cord injury,and bone remodeling,as well as the roles of the peripheral 5-HT system in the regeneration and repair of tissues such as the liver,pancreas,intestines,and skin,thereby offering new insights into the development of therapeutic strategies in stem cell therapy,tissue engineering,and regenerative medicine.METHODS:A comprehensive literature search was conducted using the databases"PubMed"and"Google Scholar."The search terms included:"5-HT,""regeneration,""tissue repair,""5-HT and tissue repair,""brain injury,""spinal cord injury,""bone reconstruction,""liver regeneration,""enteric nerve regeneration,""tissue fibrosis,""pancreatic regeneration,""skin repair,"and"inflammation."Based on the inclusion and exclusion criteria,118 articles and books were finally included for review and analysis.RESULTS AND CONCLUSION:(1)The central 5-hydroxytryptamine system facilitates cellular regeneration in injuries such as brain damage,spinal cord injury,and bone remodeling,thereby promoting tissue repair following injuries.(2)The peripheral 5-hydroxytryptamine system plays a positive role in the repair of tissues such as the liver,pancreas,intestines,and skin.(3)However,the 5-hydroxytryptamine system also exhibits adverse effects in tissue repair and regeneration,such as promoting tissue fibrosis and exacerbating inflammation.Therefore,it should be used with caution.

异质核糖核蛋白F（HNRNPF）是一种在细胞核内表达丰富的RNA结合蛋白，通过结合富含鸟嘌呤（G）的RNA调控转录与转录后加工过程影响细胞生物学行为。HNRNPF在多种恶性肿瘤中呈高表达，且其表达水平与患者预后有关。本文就HNRNPF对肿瘤细胞恶性生物学行为的影响及其免疫调控机制进行综述，并展望HNRNPF作为潜在治疗靶点的潜力，以期为肿瘤的靶向干预提供理论依据。

Objective:To summarize the clinical application and rules of Zhu Lian acupuncture and moxibustion therapy based on the relevant literature.Methods:Clinical research literature about Zhu Lian acupuncture and moxibustion therapy was retrieved from CNKI, Wanfang Data, Chongqing VIP, CBM and PubMed from the establishment of the databases to May 10, 2024. Excel 2019 was used to establish literature database. The TCM data mining system (TCM Minner) was used to analyze the clinical application of Zhu Lian acupuncture and moxibustion therapy, combination with other therapies, treatment methods, acupoint selection, needle retention time and other information.Results:A total of 95 articles were included. Zhu Lian acupuncture and moxibustion therapy was mainly used in internal medicine, surgery, gynecology, and dermatology, involving 40 diseases. Among them, the number of internal diseases was the most (19 times), followed by surgical diseases (14 times). The main diseases included stroke and its sequelae, facial paralysis, cervical spondylosis and lumbar disc herniation. There were 73 studies on the combination of other therapies, with mild moxibustion being the most widely used (21 times). In terms of manipulation, Zhu Lian inhibition of type Ⅱ acupuncture was the most widely used (26 times), followed by Zhu Lian excitation of type Ⅱ acupuncture (17 times). Acupoint selection mainly included Zusanli (45 times), Sanyinjiao (39 times), Hegu (34 times) and so on. Zhu Lian inhibition of type Ⅰ acupuncture needle retention time was mainly 30 min; Zhu Lian inhibition of type Ⅱ acupuncture was mainly 30 min, 20 min, and 15 min; Zhu Lian excitement of type Ⅰ acupuncture was mostly without needle retention; Zhu Lian excitement type Ⅱ acupuncture was mainly 10 min and 5 min; slow twisting acupuncture was mainly 30 min; Zhu Lian finger acupuncture therapy was mainly 20-25 min.Conclusion:Zhu Lian acupuncture and moxibustion therapy is mostly used to treat internal medicine and surgical diseases. Zhu Lian inhibition type Ⅱ and excitation type Ⅱ acupuncture methods are often used for treatment, and mild moxibustion therapy is often used to enhance the efficacy.

Objective To investigate the effects of 20%mannitol injection on the proliferation and apoptosis of hu-man lung squamous carcinoma cell line NCI-H292 and its possible mechanisms.Methods NCI-H292 cells were incubated with 20%and lower concentrations of mannitol.Cell proliferation and viability were detected by CCK-8 assay.Cell apoptosis was detected by flow cytometry and the expression of mitochondrial apoptosis pathway-related proteins Bcl-2 and Bax was detected by Western blot.Results Compared with the control group,mannitol inhibited cell proliferation in a dose-and time-dependent manner(P＜0.05),20%mannitol could induce cell ap-optosis(P＜0.05).The expression level of Bcl-2 was significantly reduced,while that expression level of Bax was significantly increased in cells incubated with 20%mannitol(P＜0.05).Conclusions Clinically used 20%man-nitol injection can induce apoptosis of lung squamous carcinoma cell line NCI-H292.Its mechanism is related to mi-tochondrial pathway-related proteins Bcl-2 and Bax.

Graves'ophthalmopathy(GO)is a specific autoimmune disease occurring in orbital tissues and is closely related to hyperthyroidism caused by Graves'disease(GD).Its disabling and disfiguring features significantly impact the quality of life of patients.The exact mechanism of GO still remains to be fully elucidated.In recent years,gene sequencing and medical microbiology studies have shown that changes in the gut microbiota may play a role in the development and progression of GO,with gut dysbiosis altering immune system regulatory signals and causing immune damage to organs.Clarifying the correlation between gut microbiota and GO helps to understand the disease's pathogenic mechanism and provides a theoretical basis for the diagnosis and treatment of GO.This review summarizes the impact of gut microbiota dysbiosis in the pathogenesis of GO and promising therapeutic approaches,including research progress in aspects such as gut microbiota experiments,case studies,pathogenesis,and treatment strategies.

Objective To investigate gender differences and age-related changes in body composition(BC)among Miao adults in Rongshui,Guangxi Province,and to provide the basis for assessing nutritional status and health.Methods With informed consent,630 Miao adults(218 males,412 females)were randomly selected for this study.Body composition was assessed using bioelectrical impedance analysis(BIA).Results Weight,fat-free mass,muscle mass,trunk muscle mass,limb muscle mass,waist-to-hip ratio(WHR),body water,presumtion of bone mass and protein were significantly higher in males than in females.And the fat mass,trunk fat mass,limb fat mass,visceral fat content,subcutaneous fat content and percentage of body fat were significantly higher in females than in males.According to the evaluation of body mass index(BMI)and WHR,the proportion of overweight and obesity of Miao adults was higher than the average level of Miao residents,and their obesity was characterized by central obesity.With age,weight,fat mass,muscle mass,fat-free mass,limb muscle mass,limb fat mass,subcutaneous fat content,percentage of body fat,body water,presumtion of bone mass,and protein of Rongshui Miao adults showed a gradual decreasing trend,while visceral fat content and WHR increased progressively.BMI in male Miao adults,along with BMI,fat mass,trunk fat mass,subcutaneous fat content,percentage of body fat,and body water in female Miao adults,showed a trend of increasing followed by decreasing,peaking at the age of 40-49 years.Conclusion The body composition of Miao adults in Rongshui,Guangxi,exhibits significant gender differences and age-related variation change patterns,which may increase the risk of sarcopenia and metabolic diseases with aging.

Objective To investigate the status of coexistence with cancer in young and middle-aged patients with hepatocellular carcinoma(HCC)after receiving interventional therapy,and to analyze the factors influencing the status of coexistence with cancer.Methods Using convenience sampling method,a total of 189 young and middle-aged patients with HCC,who were admitted to a certain grade Ⅲ-A hospital in the Guangxi Zhuang Autonomous Region of China from October 2023 to January 2024,were selected and used as the subjects of research.The general information questionnaire,long-term conditions questionnaire(LTCQ),stress adaptation scale(SAS),and perceived social support scale(PSSS)were used to make the relevant analysis.Results The results of LTCQ analysis showed that in the young and middle-aged HCC patients the mean LTCQ score was(66.28±5.37)points.The multivariate linear regression analysis indicated that age,per capita monthly income of family members,marital status,main caregiver,hepatitis B history,stress adaptability and perceived social support level were the main factors influencing the status of coexistence with cancer(all P＜0.05),explaining 47.0％of the variations.Conclusion The status of coexistence with cancer in young and middle-aged patients with HCC after receiving interventional therapy is at a medium level.Medical workers should implement individualized interventions for patients with different clinical features,so as to improve the quality of life of patients and prevent adverse disease outcomes.

Objective:To study the influence of surgical margins on the prognosis of anatomical hepatectomy in patients with hepatocellular carcinoma (HCC) based on a propensity score-matched (PSM) analysis.Methods:Clinical data of 200 patients with HCC undergoing anatomical hepatectomy at the Affiliated Cancer Hospital of Guangxi Medical University from December 2019 to December 2023 were retrospectively analyzed, including 169 males and 31 females, aged 53.4±12.0 years. Patients were divided into the narrow margin group (surgical margin ≤10 mm, n=133) and wide margin group (>10 mm, n=67) according to the width of the surgical margin. PSM was used to compare preoperative indicators such as the maximum diameter of the tumor, the integrity of the tumor capsule, sublesions, and the clinical stage of Barcelona liver cancer (BCLC), perioperative indicators such as intraoperative blood loss, and 24-hour postoperative laboratory indicators such as alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase between the two groups of patients. The prognosis was analyzed by the Kaplan-Meier method, and the postoperative recurrence-free survival rate of the two groups was compared by the log-rank test. Yates corrected chi-square test was used to analyze the postoperative liver function of the two groups of patients. Results:Before PSM, 133 cases were included in the narrow margin group and 67 cases in the wide margin group. There were statistically significant differences in the clinical stage of BCLC, intraoperative blood loss, alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase between the two groups (all P<0.05). After PSM, 55 cases were included in both the narrow margin group and the wide margin group. There were no statistically significant differences in the clinical stage, intraoperative blood loss, alanine aminotransferase and other indicators of BCLC between the two groups (all P>0.05). The 1-year, 2-year, and 3-year recurrence-free survival rates of the wide margin group were 94.2%, 80.1%, and 75.1% respectively, which were higher than those of the narrow margin group (71.8%, 52.9%, and 44.1%), the difference was statistically significant ( χ2=6.25, P=0.012). After PSM, a total of 12 patients (10.9%, 12/110) in the two groups developed liver dysfunction after the operation, among which 10 cases (18.2%, 10/55) were in the wide margin group and 2 cases (3.6%, 2/55). The incidence of postoperative liver dysfunction in the wide margin group was higher than that in the narrow margin group, the difference was statistically significant difference ( χ2=4.58, P=0.032). Conclusion:A surgical margin >10 mm can improve the relapse free survival rate, but it will increase the incidence of postoperative liver dysfunction.

Gastric cancer,as a highly prevalent malignant tumor worldwide,faces challenges such as insufficient targeting precision and low drug delivery efficiency in its treatment,making the development of efficient targeted delivery systems crucial for improving therapeutic efficacy.This paper systematically explores the targeting mechanisms and application potential of nanocarri-ers in gastric cancer treatment,focusing on analyzing the properties and clinical applications of metal-based nanocarriers,metal-organic frameworks,mesoporous silica nanocarriers,carbon-based nanomaterials,quantum dots,and green-synthesized inorganic nanocarriers.Aiming to pro-vide new insights and strategies for key technological breakthroughs and clinical translation in fu-ture precision therapy for gastric cancer.